Published on in Vol 5, No 2 (2016): Apr-Jun
Journals
- Glasner S, Chokron Garneau H, Ang A, Ray L, Venegas A, Rawson R, Kalichman S, Moitra E. Preliminary Efficacy of a Cognitive Behavioral Therapy Text Messaging Intervention Targeting Alcohol Use and Antiretroviral Therapy Adherence: A Randomized Clinical Trial. PLOS ONE 2020;15(3):e0229557 View
- Horvath K, Lammert S, MacLehose R, Danh T, Baker J, Carrico A. A Pilot Study of a Mobile App to Support HIV Antiretroviral Therapy Adherence Among Men Who Have Sex with Men Who Use Stimulants. AIDS and Behavior 2019;23(11):3184 View
- Chokron Garneau H, Venegas A, Rawson R, Ray L, Glasner S. Barriers to initiation of extended release naltrexone among HIV-infected adults with alcohol use disorders. Journal of Substance Abuse Treatment 2018;85:34 View
- Horvath K, Lammert S, LeGrand S, Muessig K, Bauermeister J. Using technology to assess and intervene with illicit drug-using persons at risk for HIV. Current Opinion in HIV and AIDS 2017;12(5):458 View
- Moore D, Pasipanodya E, Umlauf A, Rooney A, Gouaux B, Depp C, Atkinson J, Montoya J. Individualized texting for adherence building (iTAB) for methamphetamine users living with HIV: A pilot randomized clinical trial. Drug and Alcohol Dependence 2018;189:154 View
- Glasner S, Patrick K, Ybarra M, Reback C, Ang A, Kalichman S, Bachrach K, Garneau H, Venegas A, Rawson R. Promising outcomes from a cognitive behavioral therapy text-messaging intervention targeting drug use, antiretroviral therapy adherence, and HIV risk behaviors among adults living with HIV and substance use disorders. Drug and Alcohol Dependence 2022;231:109229 View
- Kiburi S, Kwobah E, Paruk S, Chiliza B. Feasibility, acceptability and preliminary efficacy of a cognitive behavior therapy text-message intervention among individuals with opioid use disorder in Kenya: a randomized feasibility trial. BMC Digital Health 2023;1(1) View
- Oesterle T, Hall-Flavin D, Bormann N, Loukianova L, Fipps D, Breitinger S, Gilliam W, Wu T, Correa da Costa S, Arndt S, Karpyak V. Therapeutic Content of Mobile Phone Applications for Substance Use Disorders: An Umbrella Review. Mayo Clinic Proceedings: Digital Health 2024;2(2):192 View
- Davis-Ewart L, Atkins L, Ghanooni D, Diaz J, Chuku C, Balise R, DeVries B, Miller-Perusse M, Ackley III D, Moskowitz J, McCollister K, Fardone E, Hirshfield S, Horvath K, Carrico A. Supporting treatment adherence for resilience and thriving (START): protocol for a mHealth randomized controlled trial. BMC Public Health 2024;24(1) View